SD
Salvadori Daniel Gesua Sive
Executive
OtherM
Insider track record
CEOAcross 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Salvadori Daniel Gesua Sive, Executive. Director active across 1 company, notably Abbott Laboratories. Aggregated, 15 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €505k. History available since 13 December 2021. The latest transaction was disclosed on 2 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations15 total
6,615 shares@ US$116.268.0% of flowCommon shares without par valueSEC:0001620564-26-000007:0
885 shares@ US$115.581.1% of flowCommon shares without par valueSEC:0001620564-26-000007:1
21,644 shares0Common shares without par valueSEC:0001620564-26-000002:0
1,536 shares@ US$123.282.3% of flowCommon shares without par valueSEC:0001620564-25-000009:0
8,462 shares@ US$135.8713.6% of flowCommon shares without par valueSEC:0001415889-25-006789:0
16,534 shares0Common shares without par valueSEC:0001415889-25-005918:0
23,771 shares@ US$38.4010.7% of flowCommon shares without par valueSEC:0001415889-25-002584:0
8,874 shares@ US$120.0512.1% of flowCommon shares without par valueSEC:0001415889-24-006417:0
15,673 shares0Common shares without par valueSEC:0001415889-24-005109:0
9,002 shares@ US$99.7710.4% of flowCommon shares without par valueSEC:0001415889-23-003916:0
17,700 shares0Common shares without par valueSEC:0001415889-23-003060:0
10,551 shares@ US$122.410.0005% mcap32.1% of flowCommon shares without par valueSEC:0001415889-22-002200:0
23,919 shares0Common shares without par valueSEC:0001415889-22-001744:0
23,771 shares@ US$38.400.0004% mcap22.4% of flowCommon shares without par valueSEC:0001415889-21-006263:0
3,499 shares@ US$135.000.0002% mcap11.6% of flowCommon shares without par valueSEC:0001415889-21-005967:0
About Salvadori Daniel Gesua Sive
Daniel Gesua Sive Salvadori is Executive Vice President at Abbott Laboratories. He plays a key role in the company's strategic and operational initiatives, contributing to its success in the healthcare sector.